Cortisolv
Natural health product licensed in Canada
- Licence holder
- Xymogen
- NPN or DIN-HM
- 80072535
- Status
- Active licence
- Licence date
- 14 September 2016
- Revision date
- 12 June 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Phellodendron amurense Rupr.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rhaponticum carthamoides Source : Racine | 50 milligramme | Not calculated |
| Magnolia officinalis Source : Écorce Potency : 8.5 % honokiol | 68.75 milligramme | Not calculated |
| Phellodendron amurense Source : Écorce Potency : 2.5 % berberine | 22.5 milligramme | Not calculated |
| Withania somnifera Source : Feuille Potency : 32 % Withania oligosaccharides | 150 milligramme | Not calculated |
| Withania somnifera Source : Racine Potency : 32 % Withania oligosaccharides | 150 milligramme | Not calculated |
| Withania somnifera Source : Feuille Potency : 10 % withanolides | Not specified | Not calculated |
| Withania somnifera Source : Racine Potency : 10 % withanolides | Not specified | Not calculated |
| L-théanine | 100 milligramme | Not calculated |
| Lagerstroemia speciosa Source : Feuille Potency : 1 % Corosolic acid | 48 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Amidon prégélatinisé, Triglycérides à chaîne moyenne, Amidon de maïs, silice, L-leucine, Palmitate d'ascorbyle, Microcrystalline cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Supports healthy cortisol levels, a biomarker of stress. Temporarily relieves symptoms of perceived stress. Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80072535
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.